What MidLantic Urology does

MidLantic Urology is a private, physician-led urology practice headquartered in Plymouth Meeting, Pennsylvania, formed in 2018 through the merger of leading urology groups in the Greater Philadelphia region. The practice operates 42+ clinical office locations across Philadelphia, Central, and Eastern Pennsylvania, staffed by 60+ physicians and 88 total providers (physicians, PAs, and NPs). Following the 2024 acquisition of Keystone Urology Specialists, MidLantic is the largest urology group in Pennsylvania and among the largest in the United States. The practice operates as part of the Solaris Health multi-state urology platform and is organized as MidLantic Urology LLC under Pennsylvania law.

The practice delivers the full urology continuum: urologic oncology (prostate, bladder, kidney, testicular cancers), benign prostatic hyperplasia, kidney stone management, urinary incontinence, and both men's and women's pelvic and sexual health. Clinical differentiation is anchored in advanced technology adoption, including robotic and laparoscopic surgery, SpaceOAR Hydrogel rectal spacers for prostate cancer radiotherapy, Aquablation Therapy, the Optilume BPH Catheter System, IV infusion immunotherapy (Keytruda) for non-muscle invasive bladder cancer, and the PrecisionGU genetic testing program. The practice runs a substantial clinical research operation with 500+ completed trials over 20+ years, 3,000+ patients enrolled, and 30+ active trials, supporting first-in-region and first-in-U.S. device introductions.

MidLantic operates as a professional services medical practice, generating revenue through insurance-reimbursed clinical services across office visits, procedures, surgeries, radiation oncology, and ancillary services (in-office pharmacy, interventional radiology). Distribution is direct to patients through its regional network of urology care offices, ambulatory surgery centers, three radiation oncology centers, an interventional radiology center, and a 24/7 patient portal. The company is led by Chairman Michael Hagg, Market COO Jon Mackler, and first Chief Medical Officer Dr. Guy Bernstein, with an active regional roll-up strategy evident in its 2024 Keystone acquisition.

Name

MidLantic Urology

Legal name

MidLantic Urology LLC

Website

https://midlanticurology.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

101–250 employees

Short description

MidLantic Urology is a private, physician-led urology practice operating 42+ clinical locations across Pennsylvania with 60+ physicians, delivering comprehensive urologic care spanning oncology, BPH, robotic surgery, and radiation oncology as the largest urology group in Pennsylvania.

Ownership category

akta.pro rank

Product category

Urology Healthcare Services

NAICS

Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

General Urology (HLAKAOAA)

akta.pro secondary industries

Urologic Oncology (HLAKAOAB), Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF), Female Pelvic Medicine & Reconstructive Surgery (Urogynecology) (HLAKAOAC), Urolithiasis / Kidney Stone Centers (HLAKAOAG), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD)

Keywords

• Urology care services
• Prostate cancer treatment
• Robotic surgery
• Radiation oncology
• Urologic clinical research

Headquarters

HQ city

Plymouth Meeting

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Patient Care Services: Revenue generated from medical services including office visits, procedures, surgeries, radiation oncology treatments, and diagnostic services. Services are billed through insurance plans and patients may have co-pays or deductibles.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

MidLantic Urology is a private urology medical practice providing comprehensive urologic care including diagnosis and treatment of urologic cancers (prostate, bladder, kidney, testicular), benign conditions (BPH, kidney stones, incontinence), and men's and women's sexual health. The practice operates 42 clinical office locations, ambulatory surgery centers, and radiation oncology centers staffed by 60+ physicians and 88 providers, delivering advanced minimally invasive and robotic surgical techniques, radiation oncology, genetic testing, and clinical trial access to patients across the Greater Philadelphia region.

Differentiator

Problem solved

Functional benefit

Brands

• PrecisionGU: Genetic testing program for cancer risk assessment and precision medicine

Products and services

• Urology Care / Office Consultations
• Robotic and Minimally Invasive Urologic Surgery
• Radiation Oncology for Urologic Cancers
• Ambulatory Surgery Center Services
• PrecisionGU Genetic Testing for Cancer
• Clinical Research and Clinical Trials Program
• SpaceOAR Hydrogel Rectal Spacer Treatment
• Aquablation Therapy for BPH
• Optilume BPH Catheter System
• BioProtect Balloon Spacer
• IV Infusion Immunotherapy for Bladder Cancer
• JELMYTO Treatment for Upper Tract Urothelial Cancer
• In-Office Pharmacy
• Imaging Services
• Interventional Radiology (IR) Center
• Cosan Care Coordination

Quantifiable outcome

• 92% of prostate cancer cases detected in Stages I-III
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• ZERO - The End of Prostate CancercoreStrategic or Co-development Partner · 1 January 2019MidLantic Urology helped establish the Philadelphia ZERO Prostate Cancer Run/Walk event in 2019 and hosts it annually. The partnership raises funding for prostate cancer research, local grants, transportation to treatments, and patient debt relief. Over $167,000 has been raised through the partnership.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Georgia Urology: One of the largest independent urology practices in the Southeast with broad subspecialty coverage, multiple locations, and clinical research. Directly comparable as a regional scale urology platform.
• Chesapeake Urology: Large Mid-Atlantic urology practice with similar scale, multi-site model, clinical research involvement, and proximity to MidLantic's footprint. Operates as a fellow affiliate within the broader urology consolidation landscape.
• Arizona Urology Specialists: Large multi-location urology group offering subspecialty urologic care across Arizona. Comparable on integrated multi-site delivery and clinical research participation.
• Oregon Urology Institute: Large Pacific Northwest urology group with on-site research, surgery center, and radiation oncology. Comparable as a vertically integrated, research-active single-specialty practice.
• Integrated Medical Professionals: Large multi-specialty urology and radiation oncology group serving the New York metro area. Comparable on integrated urology + radiation oncology model, scale, and multi-site clinical research operations.
• U.S. Urology Partners: Large PE-backed urology practice network with a similar multi-state consolidation strategy and clinically integrated model. Directly comparable on scale, subspecialty breadth, and growth via affiliation of independent urology groups.
• Michigan Institute of Urology: Large single-specialty urology group with multi-site footprint, on-site pathology and clinical research. Comparable on specialty-only focus and breadth of urologic subspecialties.

Broad incumbents

• New York-Presbyterian/Columbia Urology: Major academic urology program with a large multi-specialty faculty, research portfolio, and cutting-edge technique adoption. Serves as a relevant incumbent benchmark for advanced urologic care and clinical trial leadership.
• Solaris Health: National urology platform and parent operating company of MidLantic. Operates multiple affiliated urology practices across multiple states, providing shared services, capital, and clinical research infrastructure — comparable as the broader portfolio parent.

Regional players

• Tennessee Urology Associates: Large regional urology practice group serving Tennessee with multi-site delivery and clinical research involvement. Comparable scale and specialty-broad model in a different geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/MDLUrology
• Facebookfacebook.com/MidLanticUrology
• LinkedInlinkedin.com/company/midlantic-urology

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MidLantic Urology